Acute coronary syndrome in HIV patients: from pathophysiology to clinical practice
- PMID: 24282696
- PMCID: PMC3839177
- DOI: 10.3978/j.issn.2223-3652.2012.02.06
Acute coronary syndrome in HIV patients: from pathophysiology to clinical practice
Abstract
A majority of human immunodeficiency virus (HIV) infected subjects in developed countries have access to highly active anti-retroviral therapy (HAART), which is associated with significantly improved long term survival. In this setting, clinical attention needs to be focused on the impact of premature atherosclerotic cardiovascular disease (CVD), which already represents a leading cause of morbidity and mortality in these patients. While the higher prevalence of traditional risk factors remains the main culprit of increased CVD risk, HIV infection itself and antiretroviral toxicity are confounding proatherogenic factors. It is therefore critical to treat modifiable risk factors, keeping close attention to drug interactions in these patients with high cardiovascular risk profile.
Keywords: Acute coronary syndrome; highly active anti-retroviral therapy; human immunodeficiency virus.
Figures
References
-
- Henry K, Melroe H, Huebsch J, et al. Severe premature coronary artery disease with protease inhibitors. Lancet 1998;351:1328. - PubMed
-
- Friis-Møller N, Reiss P, El-Sadr W, et al. Exposure to PI and NNRTI and risk of myocardial infarction: results from the D:A:D Study. 13th Conference on Retroviruses and Opportunistic Infections; 2006; Denver, Colo.
-
- Klein D, Hurley L, Silverberg M, et al. Surveillance data for myocardial infarction hospitalizations among HIV+ and HIV- Northern Californians: 1994-2006. 14th Conference on Retroviruses and Opportunistic Infections; 2007; Los Angeles, Calif.
-
- Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 2011;53:1120-6 - PubMed
Publication types
LinkOut - more resources
Full Text Sources